FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223989755> ?p ?o ?g. }

• W4223989755 abstract "All-trans-retinoic acid (ATRA) has been clinically used to treat acute promyelocytic leukemia and is being studied to treat other types of cancer; however, the therapeutic role and mechanism of ATRA against cholangiocarcinoma (CCA) remain unclear. The present study investigated the cytotoxic effect and underlying mechanisms of ATRA on CCA cell lines. Cell viability was evaluated by sulforhodamine B assay. Intracellular reactive oxygen species (ROS) levels were assessed by dihydroethidium assay. Apoptosis analysis was performed by flow cytometry. The pathways of apoptotic cell death induction were examined using enzymatic caspase activity assay. Proteins associated with apoptosis were evaluated by western blotting. The effects on gene expression were analyzed by reverse transcription-quantitative PCR analysis. ATRA induced a concentration- and time-dependent toxicity in CCA cells. Furthermore, when the cytotoxicity of ATRA against retinoic acid receptor (RAR)-deficient cells was assessed, it was revealed that ATRA cytotoxicity was RARB-dependent. Following ATRA treatment, there was a significant accumulation of cellular ROS and ATRA-induced ROS generation led to an increase in the expression levels of apoptosis-inducing proteins and intrinsic apoptosis. Pre-treatment with ROS scavengers could diminish the apoptotic effect of ATRA, suggesting that ROS and mitochondria may have an essential role in the induction of apoptosis. Furthermore, following ATRA treatment, an increase in cellular ROS content was associated with suppressing nuclear factor erythroid 2-related factor 2 (NFE2L2 or NRF2) and NRF2-downstream active genes. ATRA also suppressed cisplatin-induced NRF2 expression, suggesting that the enhancement of cisplatin cytotoxicity by ATRA may be associated with the downregulation of NRF2 signaling. In conclusion, the results of the present study demonstrated that ATRA could be repurposed as an alternative drug for CCA therapy." @default.
• W4223989755 created "2022-04-19" @default.
• W4223989755 creator A5024484917 @default.
• W4223989755 creator A5042722834 @default.
• W4223989755 creator A5060570231 @default.
• W4223989755 creator A5072689618 @default.
• W4223989755 creator A5073891807 @default.
• W4223989755 date "2022-04-14" @default.
• W4223989755 modified "2023-10-01" @default.
• W4223989755 title "All‑<i>trans</i>‑retinoic acid induces RARB‑dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells" @default.
• W4223989755 cites W1130577162 @default.
• W4223989755 cites W1584845915 @default.
• W4223989755 cites W1584994244 @default.
• W4223989755 cites W1940769047 @default.
• W4223989755 cites W1987863639 @default.
• W4223989755 cites W2006433023 @default.
• W4223989755 cites W2007578289 @default.
• W4223989755 cites W2010077871 @default.
• W4223989755 cites W2012369608 @default.
• W4223989755 cites W2019928465 @default.
• W4223989755 cites W2041417624 @default.
• W4223989755 cites W2052568266 @default.
• W4223989755 cites W2055043067 @default.
• W4223989755 cites W2055804398 @default.
• W4223989755 cites W2060241324 @default.
• W4223989755 cites W2063801360 @default.
• W4223989755 cites W2064708887 @default.
• W4223989755 cites W2090324526 @default.
• W4223989755 cites W2104541549 @default.
• W4223989755 cites W2108177844 @default.
• W4223989755 cites W2112347626 @default.
• W4223989755 cites W2115475846 @default.
• W4223989755 cites W2121847612 @default.
• W4223989755 cites W2131749005 @default.
• W4223989755 cites W2138834435 @default.
• W4223989755 cites W2148287035 @default.
• W4223989755 cites W2151213717 @default.
• W4223989755 cites W2151656902 @default.
• W4223989755 cites W2154411476 @default.
• W4223989755 cites W2159288689 @default.
• W4223989755 cites W2163112976 @default.
• W4223989755 cites W2164022038 @default.
• W4223989755 cites W2216827809 @default.
• W4223989755 cites W2278487979 @default.
• W4223989755 cites W2303842437 @default.
• W4223989755 cites W2330249153 @default.
• W4223989755 cites W2334200141 @default.
• W4223989755 cites W2337387091 @default.
• W4223989755 cites W2467852561 @default.
• W4223989755 cites W2508132259 @default.
• W4223989755 cites W2560087117 @default.
• W4223989755 cites W2588727861 @default.
• W4223989755 cites W2605235685 @default.
• W4223989755 cites W2746588610 @default.
• W4223989755 cites W2769720204 @default.
• W4223989755 cites W2785725996 @default.
• W4223989755 cites W2790222047 @default.
• W4223989755 cites W3012732786 @default.
• W4223989755 doi "https://doi.org/10.3892/ol.2022.13299" @default.
• W4223989755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35464301" @default.
• W4223989755 hasPublicationYear "2022" @default.
• W4223989755 type Work @default.
• W4223989755 citedByCount "4" @default.
• W4223989755 countsByYear W42239897552022 @default.
• W4223989755 countsByYear W42239897552023 @default.
• W4223989755 crossrefType "journal-article" @default.
• W4223989755 hasAuthorship W4223989755A5024484917 @default.
• W4223989755 hasAuthorship W4223989755A5042722834 @default.
• W4223989755 hasAuthorship W4223989755A5060570231 @default.
• W4223989755 hasAuthorship W4223989755A5072689618 @default.
• W4223989755 hasAuthorship W4223989755A5073891807 @default.
• W4223989755 hasBestOaLocation W42239897551 @default.
• W4223989755 hasConcept C109316439 @default.
• W4223989755 hasConcept C121608353 @default.
• W4223989755 hasConcept C153911025 @default.
• W4223989755 hasConcept C185592680 @default.
• W4223989755 hasConcept C190283241 @default.
• W4223989755 hasConcept C202751555 @default.
• W4223989755 hasConcept C2776601000 @default.
• W4223989755 hasConcept C2781121885 @default.
• W4223989755 hasConcept C31573885 @default.
• W4223989755 hasConcept C48349386 @default.
• W4223989755 hasConcept C502942594 @default.
• W4223989755 hasConcept C53227056 @default.
• W4223989755 hasConcept C54355233 @default.
• W4223989755 hasConcept C55493867 @default.
• W4223989755 hasConcept C81885089 @default.
• W4223989755 hasConcept C86803240 @default.
• W4223989755 hasConcept C95444343 @default.
• W4223989755 hasConcept C96232424 @default.
• W4223989755 hasConceptScore W4223989755C109316439 @default.
• W4223989755 hasConceptScore W4223989755C121608353 @default.
• W4223989755 hasConceptScore W4223989755C153911025 @default.
• W4223989755 hasConceptScore W4223989755C185592680 @default.
• W4223989755 hasConceptScore W4223989755C190283241 @default.
• W4223989755 hasConceptScore W4223989755C202751555 @default.
• W4223989755 hasConceptScore W4223989755C2776601000 @default.
• W4223989755 hasConceptScore W4223989755C2781121885 @default.
• W4223989755 hasConceptScore W4223989755C31573885 @default.
• W4223989755 hasConceptScore W4223989755C48349386 @default.

• next